Status:
COMPLETED
Improving Adherence to Pharmacological Treatment
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Medication Adherence
Eligibility:
All Genders
30-85 years
Phase:
NA
Brief Summary
The overall goal of this study was to implement and evaluate the effects of a systems-based and pharmacist-mediated program designed to improve adherence for patients with known coronary heart disease...
Detailed Description
Patients were randomly assigned to a usual care condition which consisted of patients provided with usual care only, or to the Special Intervention (SI) condition. The intervention was implemented and...
Eligibility Criteria
Inclusion
- was between 30 and 85 years of age;
- had known CHD, defined as the presence of at least one coronary lesion at coronary angiography of \>50%.
Exclusion
- was unable or unwilling to give informed consent;
- had a history of intolerance to two or more statin drugs;
- planned to move out of the area within one year of recruitment;
- had a poor prognosis such that life expectancy was thought to be \<5 years;
- had a psychiatric illness which limited ability to participate; or
- had no telephone.
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
689 Patients enrolled
Trial Details
Trial ID
NCT00848224
Start Date
September 1 2000
End Date
May 1 2005
Last Update
February 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Memorial Medical Center
Worcester, Massachusetts, United States, 01655